Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion

Research output: Contribution to journalArticleScientificpeer-review

Abstract

A 9-year-old boy developed progressive anthracycline-induced cardiomyopathy three months after completion of chemotherapy for osteosarcoma. Five months after completion of chemotherapy, at the age of 10 years, heart transplantation was performed. At 29 months since transplantation, the patient remains free of rejection and recurrence of osteosarcoma. (Level of Difficulty: Intermediate.)

Original languageEnglish
JournalJACC: Case Reports
Volume3
Issue number15
Pages (from-to)1677-1679
Number of pages3
DOIs
Publication statusPublished - 3 Nov 2021
MoE publication typeA1 Journal article-refereed

Bibliographical note

Publisher Copyright:
© 2021 The Authors

Fields of Science

  • acute heart failure
  • cancer
  • cardiac transplantation
  • cardiomyopathy
  • pediatric surgery
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this